IZENCITINIB

Search structure
Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 2ZT81PV5UM

Structure
InChI Key DADAEARVGOQWHV-OSYLJGHBSA-N
Smile Cc1cc(Nc2cc3ncccc3c(N[C@H]3C[C@@H]4CC[C@H](C3)N4CCC#N)n2)n[nH]1
InChI
InChI=1S/C22H26N8/c1-14-10-21(29-28-14)26-20-13-19-18(4-2-8-24-19)22(27-20)25-15-11-16-5-6-17(12-15)30(16)9-3-7-23/h2,4,8,10,13,15-17H,3,5-6,9,11-12H2,1H3,(H3,25,26,27,28,29)/t15-,16-,17+

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H26N8
Molecular Weight 402.51
AlogP 3.73
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 6.0
Polar Surface Area 105.55
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 30.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Janus Kinase (JAK) inhibitor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Kinase Protein Kinase TK protein kinase group Tyrosine protein kinase JakA family
- 10 - 0.3162-50 -
Enzyme Kinase Protein Kinase TK protein kinase group Tyrosine protein kinase JakB family
- 10 - 0.3162-50 -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Inflammatory Bowel Diseases 1 D015212 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650343
DrugBank DB16660
FDA SRS 2ZT81PV5UM
CONTENTS